UroGen Pharma Ltd. (URGN)

CIK 1668243 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for UroGen Pharma Ltd..

Recent SEC filings

FiledFormAccession number
Sep 9, 202640001437749-26-029965
Sep 9, 202640001437749-26-029963
Sep 9, 20261440001976408-26-000810
Sep 9, 20261440001976408-26-000811
Aug 28, 202640001437749-26-029175
Aug 24, 202640001437749-26-028840
Aug 20, 20261440001000275-26-000100
Aug 20, 20268-K0001437749-26-028590
Aug 12, 2026SCHEDULE 13G/A0000947263-26-000072
Aug 5, 20268-K0001437749-26-025793
Aug 5, 202610-Q0001437749-26-025794
Jul 10, 202640001437749-26-023290
Jul 9, 20261440001000275-26-000093
Jun 24, 202640001437749-26-021523
Jun 24, 202640001437749-26-021513
Jun 24, 202640001437749-26-021509
Jun 24, 202640001437749-26-021515
Jun 24, 202640001437749-26-021519
Jun 24, 202640001437749-26-021511
Jun 24, 202640001437749-26-021517
Jun 23, 20268-K0001437749-26-021442
Jun 22, 20261440001000275-26-000079
Jun 9, 202640001437749-26-019964
Jun 9, 20261440001976408-26-000558
Jun 2, 20268-K0001437749-26-019102